Petros FG - Search Results

1

Plasmacytoid variant of urothelial carcinoma of the bladder manifesting as bilateral ureteral and small bowel obstruction.

Carsel A, Levy C, Raghavan AM, Ortiz JA, Sindhwani P, Petros FG. Carsel A, et al. Among authors: petros fg. Urol Case Rep. 2020 Sep 16;33:101415. doi: 10.1016/j.eucr.2020.101415. eCollection 2020 Nov. Urol Case Rep. 2020. PMID: 33102112 Free PMC article.

2

Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.

Foerster B, Abufaraj M, Petros F, Azizi M, Gupta M, Schweitzer D, Margulis V, Iwata T, Kimura S, Shabsigh A, Briganti A, Ku JH, Muilwijk T, Kassouf W, Matin SF, Spiess PE, Pierorazio PM, Hendricksen K, Shariat SF; UTUC Collaboration. Foerster B, et al. J Urol. 2020 Jun;203(6):1101-1108. doi: 10.1097/JU.0000000000000737. Epub 2020 Jan 2. J Urol. 2020. PMID: 31898919

3

Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma.

Petros FG. Petros FG. Transl Androl Urol. 2020 Aug;9(4):1794-1798. doi: 10.21037/tau.2019.11.22. Transl Androl Urol. 2020. PMID: 32944542 Free PMC article. Review.

4

Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.

Petros FG, Choi W, Qi Y, Moss T, Li R, Su X, Guo CC, Czerniak B, Dinney C, McConkey DJ, Matin SF. Petros FG, et al. J Urol. 2021 Sep;206(3):548-557. doi: 10.1097/JU.0000000000001788. Epub 2021 Apr 21. J Urol. 2021. PMID: 33881933

5

The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma.

Pletcher JP, Bhattacharjee S, Doan JP, Wynn R, Sindhwani P, Nadiminty N, Petros FG. Pletcher JP, et al. Among authors: petros fg. Front Oncol. 2021 Jul 9;11:681441. doi: 10.3389/fonc.2021.681441. eCollection 2021. Front Oncol. 2021. PMID: 34307148 Free PMC article.

6

Urine versus stent cultures and clinical UTIs.

Salari B, Khalid M, Ivan S, Ekwenna O, Petros F, Saltzman B, Sindhwani P. Salari B, et al. Int Urol Nephrol. 2021 Nov;53(11):2237-2242. doi: 10.1007/s11255-021-02964-x. Epub 2021 Jul 29. Int Urol Nephrol. 2021. PMID: 34327608

7

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth.

Bhattacharjee S, Sullivan MJ, Wynn RR, Demagall A, Hendrix AS, Sindhwani P, Petros FG, Nadiminty N. Bhattacharjee S, et al. Among authors: petros fg. BMC Cancer. 2022 Mar 23;22(1):312. doi: 10.1186/s12885-022-09376-9. BMC Cancer. 2022. PMID: 35321693 Free PMC article.

8

Muscle-invasive angiosarcoma of the urinary bladder: Case report.

Madiraju S, Nkansah-Amankra K, Buck B, Petros FG. Madiraju S, et al. Among authors: petros fg. Urol Case Rep. 2023 Oct 17;51:102593. doi: 10.1016/j.eucr.2023.102593. eCollection 2023 Nov. Urol Case Rep. 2023. PMID: 37886347 Free PMC article.

9

Reply: To PMID 25892027.

Petros FG, Angell JE, Abaza R. Petros FG, et al. Urology. 2015 Jun;85(6):1359. doi: 10.1016/j.urology.2014.11.065. Epub 2015 Apr 16. Urology. 2015. PMID: 25892026 No abstract available.

10

Outcomes of Robotic Nephrectomy Including Highest-complexity Cases: Largest Series to Date and Literature Review.

Petros FG, Angell JE, Abaza R. Petros FG, et al. Urology. 2015 Jun;85(6):1352-8. doi: 10.1016/j.urology.2014.11.063. Epub 2015 Apr 16. Urology. 2015. PMID: 25892027 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page